Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues:        
License and collaborative fees $ 1,574 $ 1,127 $ 2,578 $ 4,665
Contract and other 4,738 6,124 20,339 21,725
Total revenues 6,312 7,251 22,917 26,390
Operating expenses:        
Research and development 18,198 18,409 51,905 52,702
Selling, general and administrative 5,225 4,672 13,429 12,918
Restructuring 112 323 209 4,776
Total operating expenses 23,535 23,404 65,543 70,396
Loss from operations (17,223) (16,153) (42,626) (44,006)
Other income (expense):        
Interest expense (1,159) (1,144) (3,495) (3,211)
Other income (expense) (132) (420) 92 (542)
Revaluation of contingent warrant liabilities (11,125) (9,208) (25,745) (25,746)
Net loss before taxes (29,639) (26,925) (71,774) (73,505)
Provision for income tax benefit 15 74 15 74
Net loss (29,624) (26,851) (71,759) (73,431)
Basic and diluted net loss per common stock (in dollars per share) $ (0.34) $ (0.39) $ (0.85) $ (1.22)
Shares used in computing basic and diluted net loss per share of common stock (in shares) 87,033 68,189 84,205 60,239
Other comprehensive loss:        
Net loss (29,624) (26,851) (71,759) (73,431)
Net unrealized gains on available-for-sale securities 0 7 0 12
Comprehensive loss $ (29,624) $ (26,844) $ (71,759) $ (73,419)